000 | 00929cam a2200265 a 4500 | ||
---|---|---|---|
999 |
_c50157 _d50157 |
||
003 | BD-DhIDS | ||
005 | 20181018103801.0 | ||
008 | 020815t2002 dcu b i000 0 eng | ||
020 | _a0821352121 | ||
040 |
_aBD-DhIDS _cBD-DhIDS _dBD-DhIDS |
||
041 | _aEng | ||
086 | _aUN WB TP-437 | ||
100 | 1 | _aGovindaraj, Ramesh | |
245 | 1 | 4 |
_aThe Indian pharmaceutical sector : _bissues and options for health sector reform / _cRamesh Govindaraj & Gnanaraj Chellaraj |
260 |
_aWashington, D.C. : _bWorld Bank (WB) , _c2002 |
||
300 |
_axiii, 59p. ; _c28 cm. |
||
490 | 1 |
_aWorld Bank discussion paper, _x0259-210X ; _vno. 437 |
|
504 | _aIncludes bibliographical references (p. 48-59). | ||
650 | 0 | 4 |
_aPharmaceutical industry _zIndia |
650 | 0 | 4 |
_aDrugs _zIndia _xMarketing |
650 | 0 | 4 |
_aPharmaceutical policy _zIndia |
700 | 1 | _aChellaraj, Gnanaraj | |
830 | 0 |
_aWorld Bank discussion papers ; _vno. 437. |
|
942 |
_2ddc _cDC |